The Discounted Cash Flow (DCF) valuation of Ionis Pharmaceuticals Inc (IONS) is (57.33) USD. With the latest stock price at 37.99 USD, the upside of Ionis Pharmaceuticals Inc based on DCF is -250.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 6.8% - 9.7% | 8.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (138.13) - (35.10) | (57.33) |
| Upside | -463.6% - -192.4% | -250.9% |